Augmentation of B7 expression by herpes simplex virus antigen

Human Immunology

Volumn 64, Issue 8, 2003, Pages 780-786

  Singh, Rekha ^a,c   Kumar, Ashok ^a,b   Diaz Mitoma, Francisco ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B7 1 (CD80); B7 2 (CD86); HSV; IFN ; IL 10

Indexed keywords

B7 2 PROTEIN; B7 ANTIGEN; B7-2 PROTEIN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CONTROLLED STUDY; FETUS; FLOW CYTOMETRY; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOLOGY; IMMUNOREGULATION; METABOLISM; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VIROLOGY;

EID: 0042711017     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00103-4     Document Type: Article

References (27)

1. Corey L, Handsfield HH: Genital herpes and public health: addressing a global problem. JAMA 283:791, 2000.
2. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, Smiley JR: Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 75:750, 2001.
3. Edison KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA: Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol 76:2180, 2002.
4. Harandi AM, Svennerholm B, Holmgren J, Eriksson K: Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol 82:845, 2001.
5. Rinaldo CR Jr, Tropey DJ III: Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency 5:33, 1993.
6. Spruance SL, Evans TG, McKeough MB, Thai L, Araneo BA, Daynes RA, Mishkin EM, Abramovitz AS: Th1/Th2-like immunity and resistance to herpes simplex labialis. Antiviral Res 28:39, 1995.
7. Mossman TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348, 1986.
8. Abbas AK, Murphy K, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787, 1996.
9. Aurelian L, Ono F, Burnett J: Herpes simplex virus (HSV) associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 9:1, 2003.
10. Thomas J, Kanangat S, Rouse BT: Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res 18:681, 1998.
11. Bretscher P: The two signal model of lymphocyte activation twenty-one years later. Immunol Today 13:74, 1992.
12. Thebeau LG, Morrison LA: B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology. J Virol 76:2563, 2002.
13. Thebeau LG, Morrison LA: Mechanism of reduced T-cell effector functions and class switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation. J Virol 77:2426, 2003.
14. Edelmann KH, Wilson CB: Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J Virol 75:612, 2001.
15. Creery WD, Diaz-Mitoma F, Filion L, Kumar A: Differential modulation of B7-1 and B7-2 isoform statement on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol 26:1273, 1996.
16. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707, 1995.
17. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S: Human cytomegalovirus harbors its own unique IL-10 homolog (cmv IL-10). Proc Natl Acad Sci USA 97:1695, 2000.
18. Burysek L, Yeow WS, Pitha PM: Unique properties of a second human herpes virus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 2:19, 1999.
19. Diaz-Mitoma F, Ruben M, Sacks S, MacPherson P, Caissie G: Detection of viral DNA to review outcome of antiviral treatment of patients with recurrent genital herpes. J Clin Microbiol 34:657, 1996.
20. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L: Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 26:662, 1988.
21. Kumar A, Angel JB, Aucoin S, Creery WD, Daftarian MP, Cameron DW, Filion L, Diaz-Mitoma F: Dysregulation of B7.2 (CD86) statement on monocytes of HIV-infected individuals is associated with altered production of IL-2. Clin Exp Immunol 117:84, 1999.
22. Wetzler LW, Ho Y, Reiser H: Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 183:1151, 1996.
23. Lim W, Ma W, Gee K, Aucoin S, Nandan D, Diaz-Mitoma F, Kozlowski M, Kumar A: Distinct roles of p38 and c-Jun N-terminal kinase in IL-10-dependent and IL-10 independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells. J Immunol 168:1759, 2002.
24. Burchett SK, Corey L, Mohan KM, Westall J, Ashley R, Wilson CB: Diminished interferon-gamma in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165:813, 1992.
25. Milligan GN, Bernstein DI: Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virol 229:259, 1997.
26. Kaye PM, Rogers NJ, Curry AJ, Scott JC: Deficient statement of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 24:2850, 1994.
27. Carmack MA, Yasukawa LL, Chang SY, Tran C, Saldana F, Arvin AM, Prober CG: T cell recognition and cytokine production elicited by common and type- specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis 174:899, 1996.